Nanosized mesoporous silica particles with high colloidal stability attract growing attention as drug delivery systems for targeted cancer treatment and as bioimaging devices. This Perspective describes recent breakthroughs in mesoporous silica nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarriers. These types of nanoparticles can feature a well-defined and tunable porosity at the nanometer scale, high loading capacity, and multiple functionality for targeting and entering different types of cells. We focus on the requirements for an efficient stimuli-responsive and thus controllable release of cargo into cancer cells and discuss design principles for smart and autonomous nanocarrier systems. Mesoporous silica nanoparticles are viewed as a promising and flexible platform for numerous biomedical applications.

The structural and magnetic phase transitions of the ternary iron arsenides SrFe 2 As 2 and EuFe 2 As 2 were studied by temperature-dependent x-ray powder diffraction and 57 Fe Mössbauer spectroscopy. Both compounds crystallize in the tetragonal ThCr 2 Si 2 -type structure at room temperature and exhibit displacive structural transitions at 203 K (SrFe 2 As 2 ) or 190 K (EuFe 2 As 2 ) to orthorhombic lattice symmetry in agreement with the group-subgroup relationship between I4/mmm and F mmm. 57 Fe Mössbauer spectroscopy experiments with SrFe 2 As 2 show full hyperfine field splitting below the phase transition temperature (8.91(1) T at 4.2 K). Order parameters were extracted from detailed measurements of the lattice parameters and fitted to a simple power law. We find a relation between the critical exponents and the transition temperatures for AFe 2 As 2 compounds, which shows that the transition of BaFe 2 As 2 is indeed more continuous than the transition of SrFe 2 As 2 but it remains second order even in the latter case.

Mesoporous nanoparticles for drug delivery would benefit significantly from further improvements in targeting efficiency and endosomal release. We present a system based on colloidal mesoporous silica nanoparticles with targeting-ligands and a red-light photosensitizer. This nanoparticle system provides spatial and temporal control of the release of drugs into the cytosol of cancer cells. Furthermore, the system presents a general platform since it can be loaded with different cargos and adapted for targeting of multiple cell types.

A highly stable modular platform, based on the sequential covalent attachment of different functionalities to the surface of core-shell mesoporous silica nanoparticles (MSNs) for targeted drug delivery is presented. A reversible pH-responsive cap system based on covalently attached poly(2-vinylpyridine) (PVP) was developed as drug release mechanism. Our platform offers (i) tuneable interactions and release kinetics with the cargo drug in the mesopores based on chemically orthogonal core-shell design, (ii) an extremely robust and reversible closure and release mechanism based on endosomal acidification of the covalently attached PVP polymer block, (iii) high colloidal stability due to a covalently coupled PEG shell, and (iv) the ability to covalently attach a wide variety of dyes, targeting ligands and other functionalities at the outer periphery of the PEG shell. The functionality of the system was demonstrated in several cell studies, showing pH-triggered release in the endosome, light-triggered endosomal escape with an on-board photosensitizer, and efficient folic acid-based cell targeting.